Prenatal testing for aneuploidy in New Zealand: Time for action [7]

New Zealand Medical Journal

Volumn 118, Issue 1217, 2005, Pages

  Stone, Peter ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; GENETIC SCREENING; HEALTH PROGRAM; HUMAN; LABORATORY DIAGNOSIS; LETTER; NEW ZEALAND; PRENATAL SCREENING; SECOND TRIMESTER PREGNANCY; TRISOMY 21;

EID: 27244442850     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. Merkatz JR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetalchromosome abnormalities. Am J Obstet Gynecol. 1984;148:886-94.
2. Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first-trimester screening fro Down's syndrome. Prenat Diagn. 1997;17:821-29.
3. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Eng J Med. 1999;341: 461-76.
4. Wald NJ, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) J Med Screen. 2003;10:56-104.
5. Khoshnood B, De Vigan C, Vodovar V, et al. A population based evaluation of the impact of antenatal screening for Down's Syndrome in France, 1981-2000. BJOG 2005; 111:485-90.
6. Wapner RJ. First-Trimester Screening for Down's Syndrome. N Eng J Med 2004;350:619-21.
7. Baram DA. Termination of pregnancy for fetal abnormalities. In: Woods JR Jnr, Woods JL (editors). Loss during pregnancy or in the newborn period. principles of care with clinical cases and analyses. New Jersey: Jannetti Publications Inc; 1997, p307-30.
8. Moulder C. Understanding pregnancy loss perspectives and issues in care. London: Macmillan Press Ltd; 1998, p65-166.
9. Bishop AJ, Marteau TM, Armstrong D, et al. Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study. BJOG. 2004;111:775-9.
10. Wapner R, Thom E, Simpson JL, et al. First-trimester screening for trisomies 21 and 18 N Eng J Med. 2003;349:1405-13.
11. Cicero S, Rembouskos G, Vandecruys H, et al. Likelihood ratio for Trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan. Ultrasound Obstet Gynecol. 2004;23:218-23.
12. Wright DE, Bradbury I. Repeated measures screening for Down's Syndrome. BJOG. 2005;112:80-3.